Kidney disease end points in a pooled analysis of individual patient-level data from a large clinical trials program of the dipeptidyl peptidase 4 inhibitor linagliptin in type 2 diabetes
According to the company, "All prescribing decisions are made solely at the discretion of the clinician." If the clinician determines that treatment is not appropriate for you, you will not receive a prescription
However, there are other factors to consider, like side effects, cost, whether youre comfortable self-injecting, and availability
Li AQ, Zhao L, Zhou TF, Zhang MQ, Qin XM
Knowing where to inject is important, but medical supervision matters just as much
Research Collaborations: Programs like the ARC Centre of Excellence for Innovations in Peptide and Protein Science are leveraging Australian resources to discover novel peptides and proteins for healthcare applications